News & Updates

Show Multimedia Only

ALONE-AF: Safe to stop anticoagulant therapy after AF ablation for recurrence-free patients

15 Sep 2025 by

For individuals without documented recurrence for at least a year following catheter ablation for atrial fibrillation (AF), discontinuing oral anticoagulant therapy results in more favourable outcomes than when continued, according to the ALONE-AF trial.

ALONE-AF: Safe to stop anticoagulant therapy after AF ablation for recurrence-free patients

15 Sep 2025

What’s hot at APS & MCV 2025?

15 Sep 2025

MIMS Doctor brings you extensive coverage of the Asia Pneumonia Summit & MasterClass in Vaccinology 2025, held recently in Taipei, Taiwan. Check out the latest updates on RSV, pneumococcal disease, new vaccines, plus thought-provoking insights from respiratory experts. [READ THE FULL REPORT]

What’s hot at APS & MCV 2025?

15 Sep 2025

Reduced apical rotation linked to functional mitral regurgitation after ST-elevation MI

14 Sep 2025 by

A significant association exists between a reduced apical rotation and functional mitral regurgitation in patients with acute ST-elevation myocardial infarction (MI), suggesting a potential novel pathophysiological mechanism, reports a study.

Reduced apical rotation linked to functional mitral regurgitation after ST-elevation MI

14 Sep 2025

Routine H pylori screening in acute MI patients of no benefit

13 Sep 2025

Routine screening for Helicobacter pylori infection in patients with acute myocardial infarction (MI) does not help lower the risk of upper gastrointestinal bleeding, according to a crossover trial.

Routine H pylori screening in acute MI patients of no benefit

13 Sep 2025

Vericiguat misses endpoint in HFrEF trial

12 Sep 2025

In the treatment of patients with heart failure and reduced ejection fraction (HFrEF) and no recent worsening, the use of vericiguat falls short of reducing the risk of the composite of cardiovascular death and HF hospitalization, as shown in a phase III study.

Vericiguat misses endpoint in HFrEF trial

12 Sep 2025

Sleep disordered breathing prevalent in hypertrophic cardiomyopathy

11 Sep 2025

A significant number of patients with hypertrophic cardiomyopathy (HCM) also have sleep disordered breathing (SDB), which is linked to more severe heart problems, according to a study.

Sleep disordered breathing prevalent in hypertrophic cardiomyopathy

11 Sep 2025

Liver-related events, cardiovascular outcomes elevated in steatotic liver disease patients

11 Sep 2025

Individuals with steatotic liver disease are at an increased risk of developing liver-related events, liver cancer, and cardiovascular outcomes, reveals a study.

Liver-related events, cardiovascular outcomes elevated in steatotic liver disease patients

11 Sep 2025

Fatty acids help regulate BP levels

11 Sep 2025 by

Food-based fatty oil diets, specifically those enriched with sesame oil, and diets high in unsaturated fats significantly reduce both systolic (SBP) and diastolic blood pressure (DBP), reports a study. High intakes of monounsaturated (MUFA) and polyunsaturated fatty acid (PUFA), as well as omega-3 fatty acid diets, also result in BP reduction but to a lesser extent.

Fatty acids help regulate BP levels

11 Sep 2025

Meta-analysis favours clopidogrel over aspirin for secondary prevention in CAD

09 Sep 2025 by

In patients with established coronary artery disease (CAD), clopidogrel appears to provide superior protection against major adverse cardiovascular or cerebrovascular events (MACCE) without increasing the risk of bleeding when compared with aspirin, according to a meta-analysis.

Meta-analysis favours clopidogrel over aspirin for secondary prevention in CAD

09 Sep 2025

Apixaban recommended for thromboprophylaxis in ovarian cancer patients on chemo

09 Sep 2025 by

Data presented at ESMO Gyn 2025 support apixaban as a prophylactic agent for venous thromboembolism (VTE) in women with epithelial ovarian cancer who are undergoing neoadjuvant chemotherapy consisting of carboplatin and paclitaxel.

Apixaban recommended for thromboprophylaxis in ovarian cancer patients on chemo

09 Sep 2025

News & Updates

Filter by Specialty:

Specialty:

ALONE-AF: Safe to stop anticoagulant therapy after AF ablation for recurrence-free patients

ALONE-AF: Safe to stop anticoagulant therapy after AF ablation for recurrence-free patients

What’s hot at APS & MCV 2025?

What’s hot at APS & MCV 2025?

Reduced apical rotation linked to functional mitral regurgitation after ST-elevation MI

Reduced apical rotation linked to functional mitral regurgitation after ST-elevation MI

Routine H pylori screening in acute MI patients of no benefit

Routine H pylori screening in acute MI patients of no benefit

Vericiguat misses endpoint in HFrEF trial

Vericiguat misses endpoint in HFrEF trial

Sleep disordered breathing prevalent in hypertrophic cardiomyopathy

Sleep disordered breathing prevalent in hypertrophic cardiomyopathy

Liver-related events, cardiovascular outcomes elevated in steatotic liver disease patients

Liver-related events, cardiovascular outcomes elevated in steatotic liver disease patients

Fatty acids help regulate BP levels

Fatty acids help regulate BP levels

Meta-analysis favours clopidogrel over aspirin for secondary prevention in CAD

Meta-analysis favours clopidogrel over aspirin for secondary prevention in CAD

Apixaban recommended for thromboprophylaxis in ovarian cancer patients on chemo

Apixaban recommended for thromboprophylaxis in ovarian cancer patients on chemo